AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.
The company operates in two segments, CooperVision and CooperSurgical.
The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide.
It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing.
The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Country | United States |
IPO Date | Jan 21, 1983 |
Industry | Medical - Instruments & Supplies |
Sector | Healthcare |
Employees | 15,000 |
CEO | Albert G. White III |
Contact Details
Address: 6101 Bollinger Canyon Road San Ramon, California United States | |
Website | https://www.coopercos.com |
Stock Details
Ticker Symbol | COO |
Exchange | NASDAQ |
Fiscal Year | November - October |
Reporting Currency | USD |
CIK Code | 0000711404 |
CUSIP Number | 216648402 |
ISIN Number | US2166485019 |
Employer ID | 94-2657368 |
SIC Code | 3851 |
Key Executives
Name | Position |
---|---|
Albert G. White III | President, Chief Executive Officer & Non-Independent Director |
Brian G. Andrews | Executive Vice President, Chief Financial Officer & Treasurer |
Daniel G. McBride Esq. | Executive Vice President & Chief Operating Officer |
Agostino Ricupati CPA | Senior Vice President & Chief Accounting Officer |
Gerard H. Warner III | President of CooperVision, Inc. |
Holly R. Sheffield | President of CooperSurgical, Inc. |
Kim Duncan | Vice President of Investor Relations & Risk Management |
Nicholas S. Khadder J.D. | General Counsel & Corporate Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 12, 2024 | 4 | Filing |
Dec 12, 2024 | 4 | Filing |
Dec 12, 2024 | 4 | Filing |
Dec 12, 2024 | 4 | Filing |
Dec 12, 2024 | 4 | Filing |
Dec 12, 2024 | 4 | Filing |
Dec 12, 2024 | 4 | Filing |
Dec 06, 2024 | 10-K | Annual Report |
Dec 05, 2024 | 8-K | Current Report |
Nov 08, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |